Skip to main content
Erschienen in: Pathology & Oncology Research 4/2011

01.12.2011 | Case Report

Two Case-Reports of the Limb Salvage Treatment of Osteosarcoma Consolidated with Obvious Pathological Fractures

verfasst von: Q. Cui, D. F. Li, C. Liu, J. Guo, S. B. Liu, Y. S. Liu, J. M. Zhai, Yanjun Zeng

Erschienen in: Pathology & Oncology Research | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective

The effect of the limb salvage of the treatment of Osteosarcoma Consolidated with Obvious Pathological Fractures is not very well, the purpose of this paper is to track the efficacy of limb salvage treatment when the patients accepted the artery intervention chemotherapy and enclosed 2 clinical case-reports.

Methods

From January 2003 to September 2005, 2 clinical cases which one is a male, 29 years old, was confirmed osteosarcoma on the left distal femur, and the other is a female, 15 years old and has osteosarcoma on the right arm with obvious pathological fracture. After receiving arterial chemotherapy pump embedded, then started chemotherapy after the tumor biopsy, and the next process prosthesis replacement in limb salvage surgery after 5 times chemotherapy, follow on the next 5 times chemotherapy after the surgery.

Results

With an average follow-up 70 months, there are no postoperative infection and prosthesis loosening found, also didn’t detected tumor recurrence and metastasis, and the limb function recovered well.

Conclusions

With the effective, neoadjuvant chemotherapy and comprehensive treatment, salvage treatment is not the contraindication of the patients with pathological fractures of combined primary osteosarcoma, and the treatment with long-term follow-up effectively.
Literatur
1.
Zurück zum Zitat McKenna RJ, Schwinn CP, Soong KY et al (1966) Sarcomata of osteogenic series: an analysis of 553 cases. J Bone Joint Surg Am 48:1–26 McKenna RJ, Schwinn CP, Soong KY et al (1966) Sarcomata of osteogenic series: an analysis of 553 cases. J Bone Joint Surg Am 48:1–26
2.
Zurück zum Zitat Krugluger J, Gisinger B, Windhager R, Salzer-Kuntschik M,Kotz R (1993) Fracture in osteosarcoma. J Bone Joint Surg [Br] 75:210 Krugluger J, Gisinger B, Windhager R, Salzer-Kuntschik M,Kotz R (1993) Fracture in osteosarcoma. J Bone Joint Surg [Br] 75:210
3.
Zurück zum Zitat Kim MS, Lee SY, Lee TR et al (2009) Prognostic nomogram for predicting the 5 year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma. Ann Oncol 20:955–960PubMedCrossRef Kim MS, Lee SY, Lee TR et al (2009) Prognostic nomogram for predicting the 5 year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma. Ann Oncol 20:955–960PubMedCrossRef
4.
Zurück zum Zitat Bramer JA, van Linge JH, Grimer RJ, Scholten RJ (2009) Prognostic factors in localized extremity osteosarcoma: A systematic review. Eur J Surg Oncol 35(10):1030–1036PubMedCrossRef Bramer JA, van Linge JH, Grimer RJ, Scholten RJ (2009) Prognostic factors in localized extremity osteosarcoma: A systematic review. Eur J Surg Oncol 35(10):1030–1036PubMedCrossRef
5.
Zurück zum Zitat Scully SP, Ghert MA, Zurakowski D, Thompson RC, Gebhardt MC.Pathologic fracture in osteosarcoma : prognostic importance and treatment implications. J Bone Joint Surg Am. 2002;84-A:49-57. Scully SP, Ghert MA, Zurakowski D, Thompson RC, Gebhardt MC.Pathologic fracture in osteosarcoma : prognostic importance and treatment implications. J Bone Joint Surg Am. 2002;84-A:49-57.
6.
Zurück zum Zitat Shin KH, Rougraff BT, Simon MA (1994) Oncologic outcome of primary bone sarcoma of the pelvis. Clin Orthop 304:207–217PubMed Shin KH, Rougraff BT, Simon MA (1994) Oncologic outcome of primary bone sarcoma of the pelvis. Clin Orthop 304:207–217PubMed
7.
Zurück zum Zitat Jaffe N, Spears R, Eftekhari F et al (1987) Impact of chemotherapy on primary tumor and survival. Cancer 59(4):701–709PubMedCrossRef Jaffe N, Spears R, Eftekhari F et al (1987) Impact of chemotherapy on primary tumor and survival. Cancer 59(4):701–709PubMedCrossRef
8.
Zurück zum Zitat Adubu A, Sferopoulos NK, Tillman RM et al (1996) The surgical treatment and outcome of pathological fractures in localised osteosarcoma. J Bone Joint Surg Br 78(5):694–8 Adubu A, Sferopoulos NK, Tillman RM et al (1996) The surgical treatment and outcome of pathological fractures in localised osteosarcoma. J Bone Joint Surg Br 78(5):694–8
9.
Zurück zum Zitat Zeifang F, Sabo D, Ewerbeck V (2000) Pathological fracture in primary malignant bone tumors. Chirurg 71(9):1121–1125PubMedCrossRef Zeifang F, Sabo D, Ewerbeck V (2000) Pathological fracture in primary malignant bone tumors. Chirurg 71(9):1121–1125PubMedCrossRef
10.
Zurück zum Zitat Mayil V, Natarajan RH, Govardhan S et al (2000) Limb salvage sugery for for pathological fractures in osteosarcoma. Int Orthop 24:170–172CrossRef Mayil V, Natarajan RH, Govardhan S et al (2000) Limb salvage sugery for for pathological fractures in osteosarcoma. Int Orthop 24:170–172CrossRef
11.
Zurück zum Zitat Bacci G, Ferrari S, Longhi A (2003) Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation:local and systemic control by amputation or limb salvage after preoperative chemotherapy. Acta Orthop Scand 74(4):449–54PubMedCrossRef Bacci G, Ferrari S, Longhi A (2003) Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation:local and systemic control by amputation or limb salvage after preoperative chemotherapy. Acta Orthop Scand 74(4):449–54PubMedCrossRef
12.
Zurück zum Zitat Ebeid W, Amin S, Abdelmegid A (2005) Limb Salvage Management of Pathologic Fractures of Primary Malignant Bone Tumors. Cancer Control 12(1):57–61PubMed Ebeid W, Amin S, Abdelmegid A (2005) Limb Salvage Management of Pathologic Fractures of Primary Malignant Bone Tumors. Cancer Control 12(1):57–61PubMed
13.
Zurück zum Zitat Rongli Y, Yi G, Wanpeng X et al (2004) Surgical Treatment of Pathological Fracture Caused by Bone Tumor. Chin J Clin Oncol 31(11):620–623 Rongli Y, Yi G, Wanpeng X et al (2004) Surgical Treatment of Pathological Fracture Caused by Bone Tumor. Chin J Clin Oncol 31(11):620–623
14.
Zurück zum Zitat Huai J, Jian-jun L, Wei X et al (2008) Neoadjuvant chemotherapy combined with limb salvage surgery for treatment of extremity osteosarcoma with pathological fracture. Journal of Clinical Orthopaedics 11(3):236–239 Huai J, Jian-jun L, Wei X et al (2008) Neoadjuvant chemotherapy combined with limb salvage surgery for treatment of extremity osteosarcoma with pathological fracture. Journal of Clinical Orthopaedics 11(3):236–239
15.
Zurück zum Zitat Yibo W, Li DF (2002) Experimental and clinical of the caffeine as a cancer enhancer. Chin J Clin Oncol 29(6):450–453 Yibo W, Li DF (2002) Experimental and clinical of the caffeine as a cancer enhancer. Chin J Clin Oncol 29(6):450–453
16.
Zurück zum Zitat Eilber FC, Rosen G, Eckardt J et al (2001) Treatment-induced pathologic necrosis:a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol 19(13):3203–3209PubMed Eilber FC, Rosen G, Eckardt J et al (2001) Treatment-induced pathologic necrosis:a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol 19(13):3203–3209PubMed
Metadaten
Titel
Two Case-Reports of the Limb Salvage Treatment of Osteosarcoma Consolidated with Obvious Pathological Fractures
verfasst von
Q. Cui
D. F. Li
C. Liu
J. Guo
S. B. Liu
Y. S. Liu
J. M. Zhai
Yanjun Zeng
Publikationsdatum
01.12.2011
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 4/2011
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-010-9347-6

Weitere Artikel der Ausgabe 4/2011

Pathology & Oncology Research 4/2011 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.